Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]
Hecker DJ +11 more
europepmc +1 more source
Rate of Hearing Loss in Platinum-Naïve Patients Receiving Immune Checkpoint Inhibitors. [PDF]
Brooks KA +11 more
europepmc +1 more source
Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]
Peláez Casillas N +4 more
europepmc +1 more source
Eleutheroside E alleviates cisplatin-induced ototoxicity by down-regulating MAPK/NF-κB/NLRP3 signaling pathway and inhibiting cochlear cell pyroptosis. [PDF]
Zhang Y +12 more
europepmc +1 more source
Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells. [PDF]
Hong M, Kedeshian K, Hoffman L, Kita A.
europepmc +1 more source
Navigating the Genetic Risk of Chemotherapy-Induced Hearing Loss in the Stria Vascularis. [PDF]
Lazetic T +4 more
europepmc +1 more source
Baicalin attenuates cisplatin-induced cochlear hair cell damage by modulating the ROS-p38 MAPK signaling pathway. [PDF]
Zhang Q +7 more
europepmc +1 more source
Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review. [PDF]
Zadrożniak M +3 more
europepmc +1 more source
Hearing Characteristics of Adults before Exposure to Potentially Ototoxic Chemotherapy. [PDF]
Peruch CV +5 more
europepmc +1 more source

